His research focuses on cellular and mediator mechanisms of asthma. His greatest recognition comes from research in
acute lung injury and in the use of surfactants in the treatment of
lung diseases. Among the important
factors that could cause actual results to differ materially from those
indicated by such forward-looking statements include delays or problems in
implementation of new disease management contracts, failure to convert awards
of disease management business into implemented contracts, decreased employer
and health plan interest in or demand for the Company's disease management
programs, developments in the healthcare industry, third-party actions over
which Matria does not have control, regulatory requirements applicable to
Matria's business and the risk factors detailed from time to time in Matria's
periodic reports and registration statements filed with the Securities and
Exchange Commission, including Matria's Annual Report on From 10-K for the
year ended December 31, 2004.

respiratory spontaneous

ABOUT MATRIA HEALTHCARE
Matria Healthcare is a leading provider of comprehensive health
enhancement programs to health plans and employers . More information about Matria can be found on line at
http://www.

money chronic

"These physicians and researchers are all outstanding leaders in fighting
respiratory disease.
The two existing Matria accounts adding health enhancement programs and
services for their employees and dependents are companies in the Fortune 100
and 200.matria.

lung medication

D. She is actively engaged in research into the mechanisms and
treatment of severe asthma, serves as an editor and reviewer for a
number of journals, and has published numerous articles, book
chapters, abstracts and papers.

disease conditions

, a professor at the University of Colorado and
National Jewish Medical and Research Center. The other expanded account
had previously selected Matria's programs for diabetes, CAD, CHF, chronic
obstructive pulmonary disease, asthma, cancer and depression, and is now
adding Matria 's case management and care advocate programs.

chronic disease

, Medical Research Council (MRC) professor at the
University of Southampton School of Medicine in Southampton, England. The company is
developing a portfolio of branded respiratory products.air-pharma. We are also pleased to see that our newer programs addressing
various aspects of wellness and healthy living are in high demand by our
clients.

spontaneous traveling

Prior to airPharma,
the Dockhorns built their previous company, IMTCI, into the leader in
conducting respiratory clinical studies. airPharma is privately held and is
located in Overland Park, KS.
Particularly noteworthy is the trend we are seeing whereby existing clients
are expanding Matria's health enhancement programs for their employees and
dependents. Such statements
include but are not limited to the ability of the Company to convert awards of
business into implemented contracts, the timing of contract implementation,
the continuing demand for the Company's disease management programs and the
trend among existing accounts to expand their offering of the Company's
programs and services.

easy obstructive

-- Roger G.

About airPharma
airPharma is a specialty pharmaceutical company focused on commercializing
products that address unmet needs in respiratory diseases.

traveling disease

airPharma Names Respiratory Experts to Scientific Advisory Board

Collectively, the five new
employer accounts will represent approximately 300,000 additional covered
lives."
For the five new employer accounts, Matria will manage from four to eight
diseases and conditions in each account.

easy asthma

D.

-- Stephen Holgate, M.

lung disease

Busse, M., professor of medicine and head of the Allergy
and Clinical Immunology Department at the University of Wisconsin
School of Medicine in Madison. Menendez held academic appointments in the schools of
medicine at Tulane University and the University of New Mexico . Robert Dockhorn and Doug Dockhorn., Matria Healthcare, Inc.
Parker H. One of the existing employer
accounts expanding Matria's services has added the Company's cancer and
obesity programs to the Matria programs for diabetes, coronary artery disease
(CAD), congestive heart failure (CHF ) and asthma.

oxygen spontaneous

Recently he was named director of the
National Institutes of Health-sponsored General Clinical Research
Center at the University. MARIETTA, Ga. Both of the existing accounts that are expanding
Matria's health enhancement programs and services are self-insured employers . The new biopharma account has selected Matria's disease management
program to provide extensive patient support, education and nurse counseling
for patients utilizing a complex medication.

asthma support

-- Roger Menendez, M.

This press release contains forward-looking statements .

asthma money

She is co-director of
the Harry and Jeanette Weinberg Clinical Research Unit at National
Jewish.

Matria Healthcare Announces Awards of Six New Disease Management Accounts and Expanded Programs for Two Existing Accounts

saving cause

We are proud
to have these international experts join us in building airPharma's role in
medicine," said Doug Dockhorn, President and Chief Executive Officer .

-- Sally E. For further information, visit airPharma's
website at http://www.
(Nasdaq: MATR) announced that its Health Enhancement Division has recently
received awards of disease management programs and services from six new
accounts.
Matria's six new awards of business are with five self-insured employers
and one biopharma company.
Matria reported that these new awards and expanded accounts are in addition to
the awards of new business that the Company announced on April 14, 2005.

effects groups

The five members of the airPharma Scientific Advisory Board are:

-- William W. The company was
founded in 2002 by Dr.

conditions reseach

We share a passion for making new treatments available
for diseases of the lung and airways, such as asthma and COPD, which affect
millions of patients and represent serious unmet medical needs.com .
The five new employers selecting Matria's disease management services
include two companies in the Fortune 100, two companies in the Fortune 400 and
500, and a not-for-profit hospital system. Headquartered in Marietta,
Georgia, Matria has more than 40 offices in the United States and
internationally. These statements are based on current information and
belief, and are not guarantees of future performance.

pneumothorax diseases

Spragg, M.com.

saving breathers

, airPharma, a specialty
pharmaceutical company focusing on products to address unmet needs in
respiratory diseases, today announced a Scientific Advisory Board of five
internationally renowned experts in pulmonary medicine and respiratory
diseases.

spontaneous medication

Scientists Will Counsel Company on Drug Development and Alliances

OVERLAND PARK, Kan. The scientists bring to airPharma clinical and research expertise
in asthma, allergies, Chronic Obstructive Pulmonary Disease (COPD), and a
range of other conditions and therapies. The Company also announced an expansion of programs and services
from two of its disease management clients.

saving easy

The Scientific Advisory Board will
counsel airPharma as the company creates alliances, develops drugs and
commercializes new pharmaceutical products in the respiratory -pulmonary field. Prior to entering private practice in the
late 1980s, Dr. "Pete" Petit , Chairman and Chief Executive Officer, said, "Our
sales pipeline continues to be strong and is generating a consistent influx of
new accounts awarding their health enhancement programs to Matria. One of the
expanded accounts has completed implementation of services, and the Company
expects to implement services for one of the new accounts on January 1, 2006
and for the other new accounts and expanded accounts during the third and
fourth quarters of 2005.

disease respiratory

He
has more than two decades of experience in clinical trial design and
oversight and has published numerous articles on asthma and airway
disease treatment.D.

money reseach

He is a past president of the American
Board of Allergy and Immunology and the American Academy of Allergy,
Asthma and Immunology . Wenzel, M.

chronic diseases

D., director of the Allergy and Asthma Research
Center in El Paso, Texas., chief of medicine service at the Veterans
Affairs Medical Center in La Jolla, California, and vice chair,
Department of Medicine, at the University of California-San Diego. He
has served on the National Heart Lung and Blood Advisory Council and
the American Board of Internal Medicine subspecialty Board on
Pulmonary Disease.D.

Matria manages major
chronic diseases and episodic conditions including diabetes, congestive heart
failure, coronary artery disease, asthma, chronic obstructive pulmonary
disease, high-risk obstetrics, cancer, chronic pain, depression, end-stage
renal disease, and obesity; delivers programs that address wellness, healthy
living, productivity improvement, and patient advocacy; and provides case
management of acute and catastrophic conditions. By making these forward-looking statements,
Matria does not undertake to update them in any manner except as may be
required by Matria's disclosure obligations in filings it makes with the
Securities and Exchange Commission under the federal securities laws.

medication support

He is co-editor of the journal Clinical and Experimental Allergy,
associate editor of Clinical Science, and editor of textbooks on
asthma and allergy, as well as author of more than 700 peer-reviewed
papers and contributions.